15250-m-cuypers

41 Decision role preferences and information satisfaction 2 REFERENCES 1. Stiggelbout AM, Van Der Weijden T, De Wit MPT, Frosch D, Legare F, Montori VM, et al. Shared decision making: Really putting patients at the centre of healthcare. BMJ BMJ. 2012;344(7842). 2. Légaré F, Ratté S, Stacey D, Kryworuchko J, Gravel K, Graham ID, et al. Interventions for improving the adoption of shared decision making by healthcare professionals. The Cochrane Library. 2010. 3. LevinsonW, Kao A, Kuby A, Thisted RA. Not All PatientsWant to Participate in DecisionMaking A National Study of Public Preferences. Journal of General Internal Medicine. 2005;20(6):531- 5. 4. Elwyn G, Laitner S, Coulter A, Walker E, Watson P, Thomson R. Implementing shared decision making in the NHS. Bmj. 2010;341:c5146. 5. Singh JA, Sloan JA, Atherton PJ, Smith T, Hack TF, Huschka MM, et al. Preferred roles in treatment decision making among patients with cancer: a pooled analysis of studies using the Control Preferences Scale. The American journal of managed care. 2010;16(9):688. 6. Flynn KE, Smith MA, Vanness D. A typology of preferences for participation in healthcare decision making. Social Science & Medicine. 2006;63(5):1158-69. 7. Tariman JD, Berry DL, Cochrane B, Doorenbos A, Schepp K. Preferred and actual participation roles during health care decision making in persons with cancer: a systematic review. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO. 2010;21(6):1145-51. 8. Deber RB, Kraetschmer N, Urowitz S, Sharpe N. Do people want to be autonomous patients? Preferred roles in treatment decision-making in several patient populations. HEX Health Expectations. 2007;10(3):248-58. 9. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA: A Cancer Journal for Clinicians. 2011;61(2):69-90. 10. Hayes JH, Barry MJ. Screening for prostate cancer with the prostate-specific antigen test: A review of current evidence. JAMA. 2014;311(11):1143-9. 11. Stattin P, Carlsson S, Holmström B, Vickers A, Hugosson J, Lilja H, et al. Prostate Cancer Mortality in Areas With High and Low Prostate Cancer Incidence. Journal of the National Cancer Institute. 2014;106(3). 12. Heidenreich A, Bellmunt J, Bolla M, Joniau S, Mason M, Matveev V, et al. EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease. European urology. 2011;59(1):61-71. 13. Wilt TJ, MacDonald R, Rutks I, Shamliyan TA, Taylor BC, Kane RL. Systematic Review: Comparative Effectiveness and Harms of Treatments for Clinically Localized Prostate Cancer. Annals of Internal Medicine. 2008;148(6):435-48. 14. Lamers RED, Cuypers M, Husson O, de Vries M, Kil PJM, Ruud Bosch JLH, et al. Patients are dissatisfied with information provision: perceived information provision and quality of life in prostate cancer patients. Psycho-Oncology. 2016; 25(6): 633-640.